News

19th edition of the Asia’s largest life-sciences and Health Tech forum BioAsia, the annual flagship event of Government of Telangana will be held during February 24th and 25th, 2022 in a virtual format. The theme of this year’s edition...

Peter Soelkner featured on the “Molecule to Market” podcast Peter Soelkner, one of the managing directors at Vetter, recently sat down with Raman Sehgal of the “Molecule to Market” podcast to share his personal background, the history of Vetter, and...

It shouldn’t come as a surprise when we call India a global powerhouse when it comes to generic drugs. The Indian pharmaceutical companies cater to more than 50% of world vaccination supplies as well as 40% generic demand in...

Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Jim Kennamer as Senior Vice President and Site Head of North Carolina. With over 30 years’...

Dr Anthony Fauci, the chief medical advisor to the White House has gone on to confirm that FDA might as well approve the Pfizer and the BioNTech vaccine for children less than 5 years starting in February 2022. Fauci...

Pfizer Inc. shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. Taken together, these...

Stempeutics, a group company of Manipal Education and Medical Group (MEMG) said it has received DCGI clearance to conduct Phase 3 clinical trial on its product for treating COVID-19 patients suffering from acute respiratory distress syndrome (ARDS). The company will...